Roberto Salgado
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis
- Cytokine Signaling Pathways and Interactions
- Chemokine receptors and signaling
- Cancer Immunotherapy and Biomarkers
- Internal Medicine top 5%
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 4
- Inflammatory Biomarkers in Disease Prognosis 4
- Cancer Treatment and Pharmacology 3
-
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 6
- Co-authors
- Ina Benoy (9 shared papers)Eric Van Marck (5 shared papers)Peter Vermeulen (7 shared papers)Peter A. van Dam (7 shared papers)Luc Dirix (6 shared papers)Reinhilde Weytjens (5 shared papers)Cécile Colpaert (4 shared papers)Sara Junius (1 shared paper)
- Journals
- British Journal of Cancer (5 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Annals of Oncology (3 papers)Clinical Breast Cancer (1 paper)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
Roberto Salgado
32 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Oncology 731
- Internal Medicine 76
- Cancer Research 254
- Immunology 230
- Immunology and Allergy 40
Countries citing papers authored by Roberto Salgado
This map shows the geographic impact of Roberto Salgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Salgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Salgado more than expected).
Fields of papers citing papers by Roberto Salgado
This network shows the impact of papers produced by Roberto Salgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Salgado. The network helps show where Roberto Salgado may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Salgado, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 341 | |
| 2 | 2004 | 289 | |
| 3 | 2002 | 167 | |
| 4 | 2004 | 153 | |
| 5 | 2002 | 149 | |
| 6 | 1999 | 143 | |
| 7 | 2002 | 52 | |
| 8 | 2011 | 37 | |
| 9 | 2018 | 35 | |
| 10 | 2005 | 29 | |
| 11 | 2019 | 17 | |
| 12 | 2004 | 13 | |
| 13 | 1985 | 13 | |
| 14 | 1998 | 10 | |
| 15 | 2001 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 2019 | 6 | |
| 18 | 2000 | 6 | |
| 19 | 2015 | 5 | |
| 20 | 2019 | 5 |
About Roberto Salgado
Roberto Salgado is a scholar working on Oncology, Cancer Research, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (7 papers), Breast Cancer Treatment Studies (6 papers), Cancer Cells and Metastasis (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (731 citations), Internal Medicine (76 citations), Cancer Research (254 citations), Immunology (230 citations) and Immunology and Allergy (40 citations). Roberto Salgado has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Ina Benoy, Eric Van Marck, Peter Vermeulen, Peter A. van Dam, Luc Dirix, Reinhilde Weytjens, Luc Dirix, Cécile Colpaert, Sara Junius and P. Huget. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Cancer Research, Annals of Oncology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.